Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee; Change of Name and Function; Technical Amendment
other · Food and Drug Administration · Rule · Published 2022-03-23 · Effective 2022-03-23 · 87 FR 16393
Document
Document number
2022-05965
Federal Register citation
87 FR 16393
CFR reference
21 CFR 14
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2022-03-23
Effective date
2022-03-23
HHS docket
Docket No. FDA-2019-N-4203
Abstract
The Food and Drug Administration (FDA or Agency) is amending the standing advisory committees' regulations to change the name and function of the Bone, Reproductive and Urologic Drugs Advisory Committee. This action is being taken to reflect changes made to the charter for this advisory committee.